Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adeno-associated viral vectors for retinal gene transfer and treatment of retinal diseases.

Current gene therapy - 1 Jun 2005

Auricchio Alberto, Rolling Fabienne

Abstract excerpt

Retinal gene transfer holds big promises for the treatment of inherited and non-inherited blinding diseases, such as retinitis pigmentosa or age-related macular degeneration. Key to the development of successful gene-based therapies for the eye are efficient tools for retinal gene transfer. Vectors based on adeno-associated viruses (AAV) are able to transduce robustly and persistently different retinal cell types...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Dependovirus
Share to Disease Models, Animal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Silencing

Share to Gene Transfer Techniques

Share to Genetic Therapy

Share to Genetic Vectors

Share to Retinal Diseases

Source

Identifiers

PMID: 15975011
DOI: 10.2174/1566523054065020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adeno-associated viral vectors for retinal gene transfer and treatment of retinal diseases.PMID 15975011Read ↗

Adeno-associated virus vectors for retinal gene therapy in basic research and clinical studiesSemantic proximity Read ↗

Gene Therapy of Inherited Retinopathies: A Long and Successful Road from Viral Vectors to PatientsSemantic proximity Read ↗

Adeno-Associated Virus-Vectored Gene Therapy for Retinal DiseaseSemantic proximity Read ↗

AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy TherapiesSemantic proximity Read ↗

Novel adeno-associated viral vectors for retinal gene therapySemantic proximity Read ↗

AAV for Gene Therapy in Ocular Diseases: Progress and ProspectsSemantic proximity Read ↗

Synthetic Adeno-Associated Viral Vector Efficiently Targets Mouse and Nonhuman Primate Retina In VivoSemantic proximity Read ↗

The Future Looks Brighter After 25 Years of Retinal Gene TherapySemantic proximity Read ↗

Conventional and Tropism-Modified High-Capacity Adenoviral Vectors Exhibit Similar Transduction Profiles in Human iPSC-Derived Retinal OrganoidsSemantic proximity Read ↗

The Role of Gene Therapy in the Treatment of Retinal Diseases: A ReviewSemantic proximity Read ↗

Challenges in AAV-Based Retinal Gene Therapies and the Role of Magnetic Nanoparticle PlatformsSemantic proximity Read ↗

Gene therapy and the adeno‐associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: Trials, future directions and safety considerationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.